Skip to main content
Clean Science and Technology Limited logo

Clean Science and Technology Limited — Investor Relations & Filings

Ticker · CLEAN ISIN · INE227W01023 LEI · 335800ONLA5LRUZJZB84 BSE.NS Manufacturing
Open in API
Filings indexed 474 across all filing types
Latest filing 2025-11-06 Board/Management Inform…
Country IN India
Listing BSE.NS CLEAN

About Clean Science and Technology Limited

https://cleanscience.co.in/

Clean Science and Technology Limited specializes in the development and manufacture of specialty chemicals using sustainable and eco-friendly catalytic processes. The company focuses on green chemistry to produce high-purity performance chemicals, pharmaceutical intermediates, and FMCG ingredients. Key products include Monomethyl Ether of Hydroquinone (MEHQ), Butylated Hydroxyanisole (BHA), Ascorbyl Palmitate, Guaiacol, and 4-Methoxy Acetophenone (4-MAP). These products serve diverse global applications in the food, pharmaceutical, and personal care sectors. The company leverages proprietary technology and atom-efficient manufacturing routes to minimize waste and environmental impact, establishing itself as a global leader in several niche chemical segments through cost-effective and innovative production methodologies.

Recent filings

Filing Released Lang Actions
Appointment
Board/Management Information Classification · 90% confidence The document is a formal ‘Outcome of Board Meeting’ announcement filed with BSE and NSE under SEBI Listing Regulations. It outlines approval of un-audited quarterly and half-year financial results but does not present the actual numbers (they are enclosed as attachments). Its primary focus is on board resolutions recommending continuation, re-appointment, and appointment of several non-executive and whole-time directors. This fits Squarely within “Board/Management Information” (MANG).
2025-11-06 English
Appointment
Board/Management Information Classification · 90% confidence The document is an official letter to stock exchanges titled “Outcome of Board Meeting.” It summarizes board actions taken on 6 November 2025, including: approval of unaudited quarterly and half-year financial results, and several director appointments, re-appointments, and changes in designation. The primary content is changes in the board and senior management, disclosed under SEBI Listing Regulations, Regulation 30. This fits the “Board/Management Information” category (Code: MANG), which covers announcements of changes in the company’s board of directors or senior management. The attachment of financial results does not convert this to a full interim report; it remains a board outcome announcement.
2025-11-06 English
Appointment
Interim / Quarterly Report Classification · 88% confidence The document is a detailed disclosure under SEBI LODR (Regulation 30 & 33) containing unaudited standalone and consolidated financial results for the quarter and half-year ended 30 September 2025, together with a limited review report and extensive financial schedules (total length ≈120k characters). Although it begins as a Board Meeting outcome announcement (approvals, board changes), it encloses the full interim financial statements and auditor’s review, which meets the definition of an Interim/Quarterly Report (IR). This is more substantive than a short earnings release or mere publication notice. H1 2025
2025-11-06 English
Appointment
Interim / Quarterly Report Classification · 87% confidence The document is a stock‐exchange filing under SEBI Listing Regulations announcing the outcome of a Board meeting. It includes the approved un‐audited standalone and consolidated financial results for the quarter and half-year ended 30 September 2025 along with the Limited Review Report, meaning it contains actual financial statements for an interim period. This aligns with the definition of an Interim/Quarterly Report (IR), which are comprehensive financial reports for periods shorter than a full fiscal year and include substantive financial data and auditor commentary. Thus, it should be classified as an IR. H1 2025
2025-11-06 English
Appointment
Regulatory Filings Classification · 84% confidence The document is an “Outcome of Board Meeting” filed under SEBI LODR Regulation 30, notifying stock exchanges of approved un-audited quarterly/half-year financial results and changes in board composition (appointments/re-appointments/designation changes). It is a general regulatory announcement rather than the full interim report itself, and the key focus is on board decisions. Therefore it falls under the general “Regulatory Filings” category (RNS).
2025-11-06 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation' and is addressed to stock exchanges with a subject line explicitly stating 'Investor Presentation.' It references financial results for the quarter and half year ended 30th September 2025, and contains detailed financial data including P&L overviews, balance sheets, revenue profiles, and business updates. The content includes forward-looking statements, business strategy, and segment revenue breakdowns typical of investor presentations. The document length is about 15,000 characters, indicating it is the full presentation rather than a brief announcement. Therefore, this document fits the category of an Investor Presentation (IP).
2025-11-06 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.